A mid-size biotech wanted to launch its first infused hematology product into a competitive disease state. Xcenda conducted a reimbursement landscape assessment and gathered insights from nearly 100 pharmacy and medical directors of the Managed Care Network. Using the results to inform pricing strategy and product value story, Xcenda helped the client develop a robust suite of patient, provider and payer resources and services to facilitate a launch free of reimbursement or access hurdles.